The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids

Endocrine Reviews

Volumn 38, Issue 1, 2017, Pages 3-45

  Oster, Henrik ^a   Challet, Etienne ^b   Ott, Volker ^a   Arvat, Emanuela ^c   de Kloet, E Ronald ^d   Dijk, Derk Jan ^e   Lightman, Stafford ^f   Vgontzas, Alexandros ^g   Van Cauter, Eve ^h  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY OF TURIN   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF SURREY   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g PENN STATE COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; PREDNISONE; STEROID; TRANSCRIPTION FACTOR CLOCK;

ADRENAL INSUFFICIENCY; AGING; ARCUATE NUCLEUS; AROUSAL; BIOAVAILABILITY; BLOOD; BONE; BRAIN; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; COGNITION; CORNEA; CORTICOSTEROID BLOOD LEVEL; CUSHING SYNDROME; DEPRESSION; DIURNAL SPECIES; EATING DISORDER; ENERGY METABOLISM; FATIGUE; FOOD INTAKE; HEART; HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNE SYSTEM; IMMUNITY; INTESTINE; KIDNEY; LIMBIC CORTEX; LIVER; LUNG; MEMORY; METABOLIC REGULATION; METABOLISM; MONONUCLEAR CELL; NOCTURNAL SPECIES; NONHUMAN; OSCILLATOR; OVARY; PANCREAS ISLET BETA CELL; PHYSIOLOGICAL PROCESS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RAPHE NUCLEUS; REVIEW; SALIVARY GLAND; SHIFT WORKER; SKELETAL MUSCLE; SKIN; SLEEP DISORDER; SLEEP WAKING CYCLE; STRESS; SUPRACHIASMATIC NUCLEUS; WHITE ADIPOSE TISSUE; ANIMAL; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; GLUCOCORTICOIDS; HUMANS;

EID: 85014013803     PISSN: None     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2015-1080     Document Type: Review

References (435)

1. Pincus G. A diurnal rhythm in the excretion of urinary ketosteroids by young men. J Clin Endocrinol Metab. 1943;3(4): 195-199.
2. Migeon CJ, Tyler FH, Mahoney JP, et al. The diurnal variation of plasma levels and urinary excretion on 17-hydroxycorticosteroids in normal subjects, night workers and blind subjects. J Clin Endocrinol Metab. 1956;16(5):622-633.
3. Halberg F. Physiologic 24-hour periodicity; general and procedural considerations with reference to the adrenal cycle [in German]. Int Z Vitaminforsch Beih. 1959;10:225-296.
4. Selye H. Stress and disease. Science. 1955;122(3171):625-631.
5. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267(9):1244-1252.
6. McEwen BS. Central role of the brain in stress and adaptation: allostasis, biological embedding, and cumulative change. In: Fink G, ed. Stress: Concepts, Cognition, Emotion, and Behavior. Vol 1. Chap 5. San Diego, CA: Academic Press; 2016:39-55.
7. Herman JP, Figueiredo H, Mueller NK, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamopituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003;24(3):151-180.
8. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21(1):55-89.
9. de Kloet ER, Jöels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6(6):463-475.
10. de Kloet ER. Corticosteroid receptor balance hypothesis: implications for stress adaptation and health. In: Fink G, ed. Stress: Concepts, Cognition, Emotion, and Behavior. Vol 1. San Diego, CA: Academic Press; 2016:21-31.
11. Koolhaas JM, Bartolomucci A, Buwalda B, et al. Stress revisited: a critical evaluation of the stress concept. Neurosci Biobehav Rev. 2011;35(5):1291-1301.
12. Lazarus RS. Emotions and interpersonal relationships: toward a person-centered conceptualization of emotions and coping. J Pers. 2006;74(1):9-46.
13. McEwen BS, Gianaros PJ. Stress-and allostasis-induced brain plasticity. Annu Rev Med. 2011;62:431-445.
14. Moore RY, Eichler VB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res. 1972;42(1):201-206.
15. Stephan FK, Zucker I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA. 1972;69(6):1583-1586.
16. Inouye ST, Kawamura H. Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus. Proc Natl Acad Sci USA. 1979;76(11):5962-5966.
17. Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science. 1990;247(4945):975-978.
18. Klein DC, Moore RY, Reppert SM. Suprachiasmatic Nucleus: the Mind's Clock. 1st ed. New York, NY: Oxford University Press; 1991.
19. Van Cauter E, Aschoff J. Endocrine and other biological rhythms. In: DeGroot LJ, ed. Endocrinology. Vol. 3. Philadelphia, PA: WB Saunders; 1989;2658-2705.
20. Garaulet M, Madrid JA. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev. 2010; 62(9-10):967-978.
21. Krieger DT. Rhythms in CRF, ACTH and corticosteroids. In: Krieger DT, ed. Endocrine Rhythms. NewYork, NY: Raven Press; 1979:123-142.
22. Oster H, Damerow S, Kiessling S, et al. The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 2006;4(2):163-173.
23. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009;106(11): 4453-4458.
24. Buxton OM, Cain SW, O'Connor SP, et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4(129):129ra43.
25. Leproult R, Holmbäck U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes. 2014; 63(6):1860-1869.
26. Preuss F, Tang Y, Laposky AD, Arble D, Keshavarzian A, Turek FW. Adverse effects of chronic circadian desynchronization in animals in a "challenging" environment. Am J Physiol Regul Integr Comp Physiol. 2008;295(6):R2034-R2040.
27. Arble DM, Bass J, Laposky AD, Vitaterna MH, Turek FW. Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring). 2009;17(11):2100-2102.
28. Monk TH, Buysse DJ. Exposure to shift work as a risk factor for diabetes. J Biol Rhythms. 2013;28(5):356-359.
29. Vyas MV, Garg AX, Iansavichus AV, et al. Shift work and vascular events: systematic review and meta-analysis. BMJ. 2012;345:e4800.
30. Gan Y, Yang C, Tong X, et al. Shift work and diabetes mellitus: a meta-analysis of observational studies. Occup Environ Med. 2015;72(1):72-78.
31. Dickmeis T. Glucocorticoids and the circadian clock. J Endocrinol. 2009;200(1):3-22.
32. Dijk DJ, Duffy JF, Silva EJ, Shanahan TL, Boivin DB, Czeisler CA. Amplitude reduction and phase shifts of melatonin, cortisol and other circadian rhythms after a gradual advance of sleep and light exposure in humans. PLoS One. 2012;7(2):e30037.
33. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab. 2006;91(12): 4849-4853.
34. Knapen MH, Puts PH, van Schaik-Goodfellow MA. Addison Patients in the Netherlands: Social Report of the Survey. Summary and Recommendations. The Hague, the Netherlands: Dutch Addison Society; 1993.
35. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985;117(6):2505-2511.
36. de Kloet ER. From receptor balance to rational glucocorticoid therapy. Endocrinology. 2014;155(8):2754-2769.
37. Wyrwoll CS, Holmes MC, Seckl JR. 11b-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol. 2011;32(3):265-286.
38. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol. 2009;297(3):F559-F576.
39. Sarabdjitsingh RA, Meijer OC, Schaaf MJ, de Kloet ER. Subregion-specific differences in translocation patterns of mineralocorticoid and glucocorticoid receptors in rat hippocampus. Brain Res. 2009;1249:43-53.
40. Fuxe K, Wikström AC, Okret S, et al. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel-and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology. 1985;117(5):1803-1812.
41. Karst H, Berger S, Turiault M, Tronche F, Schütz G, Jöels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA. 2005;102(52): 19204-19207.
42. Karst H, Berger S, Erdmann G, Schütz G, JoëlsM.Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci USA. 2010;107(32):14449-14454.
43. Jöels M, Sarabdjitsingh RA, Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacol Rev. 2012;64(4):901-938.
44. Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci. 2003;23(12): 4850-4857.
45. Oitzl MS, de Kloet ER. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci. 1992;106(1):62-71.
46. de Kloet ER, Oitzl MS, Jöels M. Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci.1999;22(10): 422-426.
47. de Kloet ER, Van Acker SA, Sibug RM, et al. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int. 2000;57(4):1329-1336.
48. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10(6):434-445.
49. Vogel S, Fernández G, Jöels M, Schwabe L. Cognitive adaptation under stress: a case for the mineralocorticoid receptor. Trends Cogn Sci. 2016;20(3):192-203.
50. Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 1998;93(6):929-937.
51. Yamazaki S, Numano R, Abe M, et al. Resetting central and peripheral circadian oscillators in transgenic rats. Science. 2000; 288(5466):682-685.
52. Yoo SH, Yamazaki S, Lowrey PL, et al. PERIOD2:: LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci USA. 2004;101(15):5339-5346.
53. Nishide SY, Honma S, Nakajima Y, et al. New reporter system for Per1 and Bmal1 expressions revealed self-sustained circadian rhythms in peripheral tissues. Genes Cells. 2006;11(10):1173-1182.
54. Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci. 2012;35: 445-462.
55. Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron. 2012;74(2):246-260.
56. Dardente H, Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol Int. 2007; 24(2):195-213.
57. Ripperger JA, Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet. 2006;38(3):369-374.
58. Honma S, Kawamoto T, Takagi Y, et al. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 2002; 419(6909):841-844.
59. Ueda HR, Hayashi S, Chen W, et al. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet. 2005;37(2):187-192.
60. Ohno T, Onishi Y, Ishida N. A novel E4BP4 element drives circadian expression of mPeriod2. Nucleic Acids Res. 2007;35(2): 648-655.
61. Eckel-Mahan K, Sassone-Corsi P. Epigenetic regulation of the molecular clockwork. Prog Mol Biol Transl Sci. 2013;119:29-50.
62. Gallego M, Virshup DM. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol. 2007;8(2):139-148.
63. Jin X, Shearman LP, Weaver DR, Zylka MJ, de Vries GJ, Reppert SM. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell. 1999;96(1):57-68.
64. Tousson E, Meissl H. Suprachiasmatic nuclei grafts restore the circadian rhythm in the paraventricular nucleus of the hypothalamus. J Neurosci. 2004;24(12):2983-2988.
65. Earnest DJ, Sladek CD. Circadian rhythms of vasopressin release from individual rat suprachiasmatic explants in vitro. Brain Res. 1986;382(1):129-133.
66. Kalsbeek A, Buijs RM, Engelmann M, Wotjak CT, Landgraf R. In vivo measurement of a diurnal variation in vasopressin release in the rat suprachiasmatic nucleus. Brain Res. 1995;682(1-2):75-82.
67. Takahashi JS, DeCoursey PJ, Bauman L, Menaker M. Spectral sensitivity of a novel photoreceptive system mediating entrainment of mammalian circadian rhythms. Nature. 1984;308(5955): 186-188.
68. Khalsa SB, Jewett ME, Cajochen C, Czeisler CA. A phase response curve to single bright light pulses in human subjects. J Physiol. 2003;549(Pt 3):945-952.
69. Peirson S, Foster RG. Melanopsin: another way of signaling light. Neuron. 2006;49(3):331-339.
70. Rollag MD, Berson DM, Provencio I. Melanopsin, ganglion-cell photoreceptors, and mammalian photoentrainment. J Biol Rhythms. 2003;18(3):227-234.
71. Lucas RJ, Lall GS, Allen AE, Brown TM. How rod, cone, and melanopsin photoreceptors come together to enlighten the mammalian circadian clock. Prog Brain Res. 2012;199:1-18.
72. Dkhissi-Benyahya O, Gronfier C, De Vanssay W, Flamant F, Cooper HM. Modeling the role of mid-wavelength cones in circadian responses to light. Neuron. 2007;53(5):677-687.
73. van Diepen HC, Ramkisoensing A, Peirson SN, Foster RG, Meijer JH. Irradiance encoding in the suprachiasmatic nuclei by rod and cone photoreceptors. FASEB J. 2013;27(10):4204-4212.
74. Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000;14(23):2950-2961.
75. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M. Entrainment of the circadian clock in the liver by feeding. Science. 2001;291(5503):490-493.
76. Tahara Y, Shibata S. Chronobiology and nutrition. Neuroscience. 2013;253:78-88.
77. Sato M, Murakami M, Node K, Matsumura R, Akashi M. The role of the endocrine system in feeding-induced tissue-specific circadian entrainment. Cell Rep. 2014;8(2):393-401.
78. Landgraf D, Tsang AH, Leliavski A, et al. Oxyntomodulin regulates resetting of the liver circadian clock by food. Elife. 2015;4: e06253.
79. Minana-Solis MC, Angeles-Castellanos M, Feillet C, Pevet P, Challet E, Escobar C. Differential effects of a restricted feeding schedule on clock-gene expression in the hypothalamus of the rat. Chronobiol Int. 2009;26(5):808-820.
80. Wakamatsu H, Yoshinobu Y, Aida R, Moriya T, Akiyama M, Shibata S. Restricted-feeding-induced anticipatory activity rhythm is associated with a phase-shift of the expression of mPer1 and mPer2 mRNA in the cerebral cortex and hippocampus but not in the suprachiasmatic nucleus of mice. Eur J Neurosci. 2001;13(6): 1190-1196.
81. Feillet CA, Mendoza J, Albrecht U, Pévet P, Challet E. Forebrain oscillators ticking with different clock hands. Mol Cell Neurosci. 2008;37(2):209-221.
82. Guilding C, Hughes AT, Brown TM, Namvar S, Piggins HD. A riot of rhythms: neuronal and glial circadian oscillators in the mediobasal hypothalamus. Mol Brain. 2009;2:28.
83. Mendoza J, Gourmelen S, Dumont S, Sage-Ciocca D, Pévet P, Challet E. Setting the main circadian clock of a diurnal mammal by hypocaloric feeding. J Physiol. 2012;590(13):3155-3168.
84. Kräuchi K, Cajochen C, Werth E, Wirz-Justice A. Alteration of internal circadian phase relationships after morning versus evening carbohydrate-rich meals in humans. J Biol Rhythms. 2002;17(4):364-376.
85. Roky R, Houti I, Moussamih S, Qotbi S, Aadil N. Physiological and chronobiological changes during Ramadan intermittent fasting. Ann Nutr Metab. 2004;48(4):296-303.
86. Bogdan A, Bouchareb B, Touitou Y. Response of circulating leptin to Ramadan daytime fasting: a circadian study. Br J Nutr. 2005; 93(4):515-518.
87. Bogdan A, Bouchareb B, Touitou Y. Ramadan fasting alters endocrine and neuroendocrine circadian patterns. Meal-time as a synchronizer in humans? Life Sci. 2001;68(14):1607-1615.
88. Challet E. Interactions between light, mealtime and calorie restriction to control daily timing in mammals. J Comp Physiol B. 2010;180(5):631-644.
89. Kohsaka A, Laposky AD, Ramsey KM, et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 2007;6(5):414-421.
90. Mendoza J, Pévet P, Challet E. High-fat feeding alters the clock synchronization to light. J Physiol. 2008;586(24):5901-5910.
91. Van Reeth O, Turek FW. Stimulated activity mediates phase shifts in the hamster circadian clock induced by dark pulses or benzodiazepines. Nature. 1989;339(6219):49-51.
92. Mrosovsky N. Locomotor activity and non-photic influences on circadian clocks. Biol Rev Camb Philos Soc. 1996;71(3): 343-372.
93. Hughes AT, Piggins HD. Feedback actions of locomotor activity to the circadian clock. Prog Brain Res. 2012;199:305-336.
94. Buxton OM, Lee CW, L'Hermite-Baleriaux M, Turek FW, Van Cauter E. Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase. Am J Physiol Regul Integr Comp Physiol. 2003;284(3):R714-R724.
95. Brown SA, Zumbrunn G, Fleury-Olela F, Preitner N, Schibler U. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr Biol. 2002;12(18):1574-1583.
96. Buhr ED, Yoo SH, Takahashi JS. Temperature as a universal resetting cue for mammalian circadian oscillators. Science. 2010; 330(6002):379-385.
97. Guo H, Brewer JM, Champhekar A, Harris RB, Bittman EL. Differential control of peripheral circadian rhythms by suprachiasmatic-dependent neural signals. Proc Natl Acad Sci USA. 2005;102(8):3111-3116.
98. Kornmann B, Schaad O, Bujard H, Takahashi JS, Schibler U. System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol. 2007;5(2):e34.
99. Pevet P, Challet E. Melatonin: both master clock output and internal time-giver in the circadian clocks network. J Physiol Paris. 2011;105(4-6):170-182.
100. Dardente H. Does a melatonin-dependent circadian oscillator in the pars tuberalis drive prolactin seasonal rhythmicity? J Neuroendocrinol. 2007;19(8):657-666.
101. Yanovski JA, Rosenwasser AM, Levine JD, Adler NT. The circadian activity rhythms of rats with mid-and parasagittal 'split-SCN' knife cuts and pinealectomy. Brain Res. 1990;537(1-2): 216-226.
102. Torres-Farfan C, Rocco V, Monsó C, et al. Maternal melatonin effects on clock gene expression in a nonhuman primate fetus. Endocrinology. 2006;147(10):4618-4626.
103. Mendez N, Abarzua-Catalan L, Vilches N, et al. Timed maternal melatonin treatment reverses circadian disruption of the fetal adrenal clock imposed by exposure to constant light. PLoS One. 2012;7(8):e42713.
104. Cailotto C, van Heijningen C, van der Vliet J, et al. Daily rhythms in metabolic liver enzymes and plasma glucose require a balance in the autonomic output to the liver. Endocrinology. 2008;149(4): 1914-1925.
105. Terazono H, Mutoh T, Yamaguchi S, et al. Adrenergic regulation of clock gene expression in mouse liver. Proc Natl Acad Sci USA. 2003;100(11):6795-6800.
106. Buijs RM, Wortel J, Van Heerikhuize JJ, et al. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci. 1999;11(5): 1535-1544.
107. Kalsbeek A, van der Spek R, Lei J, Endert E, Buijs RM, Fliers E. Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis. Mol Cell Endocrinol. 2012;349(1): 20-29.
108. Ishida A, Mutoh T, Ueyama T, et al. Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab. 2005;2(5):297-307.
109. Kiessling S, Sollars PJ, Pickard GE. Light stimulates the mouse adrenal through a retinohypothalamic pathway independent of an effect on the clock in the suprachiasmatic nucleus. PLoS One. 2014;9(3):e92959.
110. Perreau-Lenz S, Kalsbeek A, Garidou ML, et al. Suprachiasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanisms. Eur J Neurosci. 2003;17(2):221-228.
111. Vujovic N, Davidson AJ, Menaker M. Sympathetic input modulates, but does not determine, phase of peripheral circadian oscillators. Am J Physiol Regul Integr Comp Physiol. 2008; 295(1):R355-R360.
112. Son GH, Chung S, Kim K. The adrenal peripheral clock: glucocorticoid and the circadian timing system. Front Neuroendocrinol. 2011;32(4):451-465.
113. Copinschi G, Challet E. Endocrine rhythms, the sleep-wake cycle, and biological clocks. In: Jameson JL, De Groot LJ, eds. Endocrinology: Adult and Pediatric. 7th ed. Philadelphia, PA: Saunders; 2015:147-173.
114. Copinschi G, Turek FW, Van Cauter E. Endocrine rhythms, the sleep-wake cycle and biological clocks. In: Jameson LJ, DeGroot LJ, eds. Endocrinology. 6th ed. Philadelphia, PA: Elsevier-Saunders. 2010;199-229.
115. Van Cauter E, Honinckx E. Pulsatility of pituitary hormones. Exp Brain Res Suppl. 1985;12:41-60.
116. Lejeune-Lenain C, Van Cauter E, Désir D, Beyloos M, Franckson JR. Control of circadian and episodic variations of adrenal androgens secretion in man. J Endocrinol Invest. 1987;10(3): 267-276.
117. Guyon A, Balbo M, Morselli LL, et al. Adverse effects of two nights of sleep restriction on the hypothalamic-pituitary-adrenal axis in healthy men. J Clin Endocrinol Metab. 2014;99(8): 2861-2868.
118. Dorn LD, Lucke JF, Loucks TL, BergaSL. Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann Clin Biochem. 2007;44(Pt 3):281-284.
119. Vagnucci AI, Hesser ME, Kozak GP, Pauk GL, Lauler DP, Thorn GW. Circadian cycle of urinary cortisol in healthy subjects and in Cushing's syndrome. J Clin Endocrinol Metab. 1965;25(10): 1331-1339.
120. Sousa MB, Ziegler TE. Diurnal variation on the excretion patterns of fecal steroids in common marmoset (Callithrix jacchus) females. Am J Primatol. 1998;46(2):105-117.
121. Tsang AH, Barclay JL, Oster H. Interactions between endocrine and circadian systems. J Mol Endocrinol. 2014;52(1):R1-R16.
122. Abe K, Kroning J, Greer MA, Critchlow V. Effects of destruction of the suprachiasmatic nuclei on the circadian rhythms in plasma corticosterone, body temperature, feeding and plasma thyrotropin. Neuroendocrinology. 1979;29(2): 119-131.
123. Meyer-Bernstein EL, Jetton AE, Matsumoto SI, Markuns JF, Lehman MN, Bittman EL. Effects of suprachiasmatic transplants on circadian rhythms of neuroendocrine function in golden hamsters. Endocrinology. 1999;140(1):207-218.
124. Gillette MU, Reppert SM. The hypothalamic suprachiasmatic nuclei: circadian patterns of vasopressin secretion and neuronal activity in vitro. Brain Res Bull. 1987;19(1):135-139.
125. Kalsbeek A, Verhagen LA, Schalij I, et al. Opposite actions of hypothalamic vasopressin on circadian corticosterone rhythm in nocturnal versus diurnal species. Eur J Neurosci. 2008;27(4): 818-827.
126. VrangN, Larsen PJ, Mikkelsen JD. Direct projection from the suprachiasmatic nucleus to hypophysiotrophic corticotropinreleasing factor immunoreactive cells in the paraventricular nucleus of the hypothalamus demonstrated by means of Phaseolus vulgaris-leucoagglutinin tract tracing. Brain Res. 1995;684(1): 61-69.
127. Abe M, Herzog ED, Yamazaki S, et al. Circadian rhythms in isolated brain regions. J Neurosci. 2002;22(1):350-356.
128. Watts AG, Tanimura S, Sanchez-Watts G. Corticotropin-releasing hormone and arginine vasopressin gene transcription in the hypothalamic paraventricular nucleus of unstressed rats: daily rhythms and their interactions with corticosterone. Endocrinology. 2004;145(2):529-540.
129. Girotti M, Weinberg MS, Spencer RL. Diurnal expression of functional and clock-related genes throughout the rat HPA axis: system-wide shifts in response to a restricted feeding schedule.Am J Physiol Endocrinol Metab. 2009;296(4):E888-E897.
130. Ur E, Capstick C, McLoughlin L, Checkley S, Besser GM, Grossman A. Continuous administration of human corticotropinreleasing hormone in the absence of glucocorticoid feedback in man. Neuroendocrinology. 1995;61(2):191-197.
131. De Kloet ER, Vreugdenhil E, Oitzl MS, Jöels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998; 19(3):269-301.
132. JöelsM, Karst H, DeRijk R, deKloet ER. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008;31(1):1-7.
133. Bur IM, Zouaoui S, Fontanaud P, et al. The comparison between circadian oscillators in mouse liver and pituitary gland reveals different integration of feeding and light schedules. PLoS One. 2010;5(12):e15316.
134. Wunderer F, Kühne S, Jilg A, et al. Clock gene expression in the human pituitary gland. Endocrinology. 2013;154(6): 2046-2057.
135. Cascio CS, Shinsako J, Dallman MF. The suprachiasmatic nuclei stimulate evening ACTH secretion in the rat. Brain Res. 1987; 423(1-2):173-178.
136. Sage D, Maurel D, Bosler O. Corticosterone-dependent driving influence of the suprachiasmatic nucleus on adrenal sensitivity to ACTH. Am J Physiol Endocrinol Metab. 2002; 282(2):E458-E465.
137. Sage D, Maurel D, Bosler O. Involvement of the suprachiasmatic nucleus in diurnal ACTH and corticosterone responsiveness to stress. Am J Physiol Endocrinol Metab. 2001;280(2):E260-E269.
138. Ulrich-Lai YM, Arnhold MM, EngelandWC. Adrenal splanchnic innervation contributes to the diurnal rhythm of plasma corticosterone in rats by modulating adrenal sensitivity to ACTH.AmJ Physiol Regul Integr Comp Physiol. 2006;290(4):R1128-R1135.
139. Oster H, Damerow S, Hut RA, Eichele G. Transcriptional profiling in the adrenal gland reveals circadian regulation of hormone biosynthesis genes and nucleosome assembly genes. J Biol Rhythms. 2006;21(5):350-361.
140. Son GH, Chung S, Choe HK, et al. Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc Natl Acad Sci USA. 2008;105(52):20970-20975.
141. Yoder JM, Brandeland M, Engeland WC. Phase-dependent resetting of the adrenal clock by ACTH in vitro. Am J Physiol Regul Integr Comp Physiol. 2014;306(6):R387-R393.
142. Leliavski A, Shostak A, Husse J, Oster H. Impaired glucocorticoid production and response to stress in Arntl-deficient male mice. Endocrinology. 2014;155(1):133-142.
143. Barclay JL, Tsang AH, Oster H. Interaction of central and peripheral clocks in physiological regulation. Prog Brain Res. 2012; 199:163-181.
144. Van Cauter E, Blackman JD, Roland D, Spire JP, Refetoff S, Polonsky KS. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest. 1991; 88(3):934-942.
145. Czeisler CA, Klerman EB. Circadian and sleep-dependent regulation of hormone release in humans. Recent Prog Horm Res. 1999;54:97-130; discussion 130-132.
146. Van Cauter E, Shapiro ET, Tillil H, Polonsky KS. Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am J Physiol. 1992;262(4 Pt 1):E467-E475.
147. Cryer PE. Hypoglycemia: Pathophysiology, Diagnosis, and Treatment. New York, NY: Oxford University Press; 1997: 1-184.
148. Wilkinson CW, Shinsako J, Dallman MF. Daily rhythms in adrenal responsiveness to adrenocorticotropin are determined primarily by the time of feeding in the rat. Endocrinology. 1979; 104(2):350-359.
149. Leal AM, Forsling ML, Moreira AC. Diurnal variation of the pituitary-adrenal and AVP responses to stress in rats under food restriction. Life Sci. 1995;56(3):191-198.
150. Mitome M, Honma S, Yoshihara T, Honma K. Prefeeding increase in paraventricular NE release is regulated by a feedingassociated rhythm in rats. Am J Physiol. 1994;266(4 Pt 1): E606-E611.
151. Mistlberger RE. Neurobiology of food anticipatory circadian rhythms. Physiol Behav. 2011;104(4):535-545.
152. Bahijri S, Borai A, Ajabnoor G, et al. Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan. PLoS One. 2013;8(4): e60917.
153. Leproult R, Colecchia EF, L'Hermite-Balériaux M, Van Cauter E. Transition from dim to bright light in the morning induces an immediate elevation of cortisol levels. J Clin Endocrinol Metab. 2001;86(1):151-157.
154. Otawa M, Arai H, Atomi Y. Molecular aspects of adrenal regulation for circadian glucocorticoid synthesis by chronic voluntary exercise. Life Sci. 2007;80(8):725-731.
155. Droste SK, Collins A, Lightman SL, Linthorst AC, Reul JM. Distinct, time-dependent effects of voluntary exercise on circadian and ultradian rhythms and stress responses of free corticosterone in the rat hippocampus. Endocrinology. 2009;150(9):4170-4179.
156. Kanaley JA, Weltman JY, Pieper KS, Weltman A, Hartman ML. Cortisol and growth hormone responses to exercise at different times of day. J Clin Endocrinol Metab. 2001;86(6): 2881-2889.
157. Labsy Z, Prieur F, Le Panse B, et al. The diurnal patterns of cortisol and dehydroepiandrosterone in relation to intense aerobic exercise in recreationally trained soccer players. Stress. 2013;16(2): 261-265.
158. Atkinson HC, Wood SA, Kershaw YM, Bate E, Lightman SL. Diurnal variation in the responsiveness of the hypothalamicpituitary-adrenal axis of the male rat to noise stress. J Neuroendocrinol. 2006;18(7):526-533.
159. KalsbeekA, RuiterM, La Fleur SE, VanHeijningenC, BuijsRM.The diurnal modulation of hormonal responses in the rat varies with different stimuli. J Neuroendocrinol. 2003;15(12):1144-1155.
160. Kino T, Chrousos GP. Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: implications for cardiometabolic diseases. Endocr Dev. 2011;20:116-126.
161. Rosmond R, Dallman MF, Bjö rntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 1998;83(6):1853-1859.
162. Linkowski P, Mendlewicz J, Leclercq R, et al. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab. 1985;61(3):429-438.
163. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry. 1996; 40(2):79-88.
164. Jarcho MR, Slavich GM, Tylova-Stein H, Wolkowitz OM, Burke HM. Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder. Biol Psychol. 2013;93(1):150-158.
165. Vgontzas AN, Bixler EO, Lin HM, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamicpituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86(8):3787-3794.
166. Quabbe HJ, Gregor M, Bumke-Vogt C, Härdel C. Pattern of plasma cortisol during the 24-hour sleep/wake cycle in the rhesus monkey. Endocrinology. 1982;110(5):1641-1646.
167. Dallman MF, Strack AM, Akana SF, et al. Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol. 1993;14(4):303-347.
168. Caldelas I, Poirel VJ, Sicard B, Pévet P, Challet E. Circadian profile and photic regulation of clock genes in the suprachiasmatic nucleus of a diurnal mammal Arvicanthis ansorgei. Neuroscience. 2003;116(2):583-591.
169. Dardente H, Menet JS, Challet E, Tournier BB, Pévet P, Masson-Pévet M. Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of nocturnal and diurnal rodents. Brain Res Mol Brain Res. 2004;124(2):143-151.
170. Smale L, Lee T, Nunez AA. Mammalian diurnality: some facts and gaps. J Biol Rhythms. 2003;18(5):356-366.
171. Walker JJ, Terry JR, Lightman SL. Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis. Proc Biol Sci. 2010; 277(1688):1627-1633.
172. Walker JJ, Spiga F, Waite E, et al. The origin of glucocorticoid hormone oscillations. PLoS Biol. 2012;10(6):e1001341.
173. Waite EJ, McKenna M, Kershaw Y, et al. Ultradian corticosterone secretion is maintained in the absence of circadian cues. Eur J Neurosci. 2012;36(8):3142-3150.
174. Spiga F, Waite EJ, Liu Y, Kershaw YM, Aguilera G, Lightman SL. ACTH-dependent ultradian rhythm of corticosterone secretion. Endocrinology. 2011;152(4):1448-1457.
175. Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci. 2010;11(10):710-718.
176. Walker JJ, Spiga F, Gupta R, Zhao Z, Lightman SL, Terry JR. Rapid intra-adrenal feedback regulation of glucocorticoid synthesis. J R Soc Interface. 2015;12(102):20140875.
177. Spiga F, Lightman SL. Dynamics of adrenal glucocorticoid steroidogenesis in health and disease. Mol Cell Endocrinol. 2015; 408:227-234.
178. Gibbison B, Spiga F, Walker JJ, et al. Dynamic pituitary-adrenal interactions in response to cardiac surgery. Crit Care Med. 2015; 43(4):791-800.
179. Stavreva DA, Wiench M, John S, et al. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol. 2009;11(9): 1093-1102.
180. Conway-Campbell BL, George CL, Pooley JR, et al. The HSP90 molecular chaperone cycle regulates cyclical transcriptional dynamics of the glucocorticoid receptor and its coregulatory molecules CBP/p300 during ultradian ligand treatment.Mol Endocrinol. 2011; 25(6):944-954.
181. Stavreva DA, Coulon A, Baek S, et al. Dynamics of chromatin accessibility and long-range interactions in response to glucocorticoid pulsing. Genome Res. 2015;25(6):845-857.
182. Sarabdjitsingh RA, Conway-Campbell BL, Leggett JD, et al. Stress responsiveness varies over the ultradian glucocorticoid cycle in a brainregion-specific manner. Endocrinology. 2010;151(11):5369-5379.
183. Sarabdjitsingh RA, Jezequel J, Pasricha N, et al. Ultradian corticosterone pulses balance glutamatergic transmission and synaptic plasticity. Proc Natl Acad Sci USA. 2014; 111(39): 14265-14270.
184. Young EA, Ribeiro SC, Ye W. Sex differences in ACTH pulsatility following metyrapone blockade in patients with major depression. Psychoneuroendocrinology. 2007;32(5):503-507.
185. Henley DE, Russell GM, Douthwaite JA, et al. Hypothalamicpituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab. 2009;94(11):4234-4242.
186. Koyanagi S, Okazawa S, Kuramoto Y, et al. Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues. Mol Endocrinol. 2006; 20(3):573-583.
187. Sage D, Ganem J, Guillaumond F, et al. Influence of the corticosterone rhythm on photic entrainment of locomotor activity in rats. J Biol Rhythms. 2004;19(2):144-156.
188. Rosenfeld P, Van Eekelen JA, Levine S, De Kloet ER. Ontogeny of the type 2 glucocorticoid receptor in discrete rat brain regions: an immunocytochemical study. Brain Res. 1988;470(1):119-127.
189. Su Y, van der Spek R, Foppen E, Kwakkel J, Fliers E, Kalsbeek A. Effects of adrenalectomy on daily gene expression rhythms in the rat suprachiasmatic and paraventricular hypothalamic nuclei and in white adipose tissue. Chronobiol Int. 2015;32(2):211-224.
190. Kiessling S, Eichele G, Oster H. Adrenal glucocorticoids have a key role in circadian resynchronization in a mouse model of jet lag. J Clin Invest. 2010;120(7):2600-2609.
191. Takahashi S, Yokota S, Hara R, et al. Physical and inflammatory stressors elevate circadian clock gene mPer1 mRNA levels in the paraventricular nucleus of the mouse. Endocrinology. 2001; 142(11):4910-4917.
192. Al-Safadi S, Branchaud M, Rutherford S, Amir S. Glucocorticoids and stress-induced changes in the expression of PERIOD1 in the rat forebrain. PLoS One. 2015;10(6):e0130085.
193. Hughes AT, Guilding C, Piggins HD. Neuropeptide signaling differentially affects phase maintenance and rhythm generation in SCN and extra-SCN circadian oscillators. PLoS One. 2011;6(4): e18926.
194. Uchoa ET, Silva LE, de Castro M, Antunes-Rodrigues J, Elias LL. Glucocorticoids are required for meal-induced changes in the expression of hypothalamic neuropeptides. Neuropeptides. 2012; 46(3):119-124.
195. Shimizu H, Arima H, Ozawa Y, et al. Glucocorticoids increase NPY gene expression in the arcuate nucleus by inhibiting mTOR signaling in rat hypothalamic organotypic cultures. Peptides. 2010;31(1):145-149.
196. Segall LA, Perrin JS, Walker CD, Stewart J, Amir S. Glucocorticoid rhythms control the rhythm of expression of the clock protein, Period2, in oval nucleus of the bed nucleus of the stria terminalis and central nucleus of the amygdala in rats. Neuroscience. 2006;140(3):753-757.
197. Gilhooley MJ, Pinnock SB, Herbert J. Rhythmic expression of per1 in the dentate gyrus is suppressed by corticosterone: implications for neurogenesis. Neurosci Lett. 2011;489(3): 177-181.
198. Conway-Campbell BL, Sarabdjitsingh RA, McKenna MA, et al. Glucocorticoid ultradian rhythmicity directs cyclical gene pulsing of the clock gene period 1 in rat hippocampus. J Neuroendocrinol. 2010;22(10):1093-1100.
199. Malek ZS, Sage D, Pévet P, Raison S. Daily rhythm of tryptophan hydroxylase-2 messenger ribonucleic acid within raphe neurons is induced by corticoid daily surge and modulated by enhanced locomotor activity. Endocrinology. 2007;148(11):5165-5172.
200. Balsalobre A, Brown SA, Marcacci L, et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science. 2000;289(5488):2344-2347.
201. Sujino M, Furukawa K, Koinuma S, et al. Differential entrainment of peripheral clocks in the rat by glucocorticoid and feeding. Endocrinology. 2012;153(5):2277-2286.
202. Reddy AB, Maywood ES, Karp NA, et al. Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology. 2007;45(6):1478-1488.
203. Oishi K, Amagai N, Shirai H, Kadota K, OhkuraN, Ishida N. Genome-wide expression analysis reveals 100 adrenal glanddependent circadian genes in the mouse liver. DNA Res. 2005; 12(3):191-202.
204. Ikeda Y, Sasaki H, Ohtsu T, Shiraishi T, Tahara Y, Shibata S. Feeding and adrenal entrainment stimuli are both necessary for normal circadian oscillation of peripheral clocks in mice housed under different photoperiods. Chronobiol Int. 2015;32(2): 195-210.
205. Pezük P, Mohawk JA, Wang LA, MenakerM. Glucocorticoids as entraining signals for peripheral circadian oscillators. Endocrinology. 2012;153(10):4775-4783.
206. Takahashi K, Yamada T, Tsukita S, et al. Chronic mild stress alters circadian expressions of molecular clock genes in the liver. Am J Physiol Endocrinol Metab. 2013;304(3):E301-E309.
207. Almon RR, Yang E, Lai W, et al. Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2008; 295(4):R1031-R1047.
208. Marcheva B, Ramsey KM, Buhr ED, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010;466(7306):627-631.
209. Sadacca LA, Lamia KA, deLemos AS, Blum B, Weitz CJ. An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice. Diabetologia. 2011;54(1):120-124.
210. Barnea M, Madar Z, Froy O. Dexamethasone induces highamplitude rhythms in preadipocytes, but hinders circadian expression in differentiated adipocytes. Chronobiol Int. 2013;30(6): 837-842.
211. Gómez-Abellań P, Díez-Noguera A, Madrid JA, Lujań JA, Ordovás JM, Garaulet M. Glucocorticoids affect 24 h clock genes expression in human adipose tissue explant cultures. PLoS One. 2012;7(12):e50435.
212. Pan X, Hussain MM. Clock is important for food and circadian regulation of macronutrient absorption in mice. J Lipid Res. 2009; 50(9):1800-1813.
213. Hoogerwerf WA, Hellmich HL, Cornelissen G, et al. Clock gene expression in the murine gastrointestinal tract: endogenous rhythmicity and effects of a feeding regimen. Gastroenterology. 2007;133(4):1250-1260.
214. Sl ádek M, Rybová M, Jindr áková Z, et al. Insight into the circadian clock within rat colonic epithelial cells. Gastroenterology. 2007;133(4):1240-1249.
215. Thaiss CA, Zeevi D, Levy M, et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014;159(3):514-529.
216. Liang X, Bushman FD, FitzGerald GA. Time in motion: the molecular clock meets the microbiome. Cell. 2014;159(3): 469-470.
217. Leone V, Gibbons SM, Martinez K, et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe. 2015;17(5): 681-689.
218. Gibbs J, Ince L, Matthews L, et al. An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action. Nat Med. 2014;20(8):919-926.
219. Burioka N, Takata M, Okano Y, et al. Dexamethasone influences human clock gene expression in bronchial epithelium and peripheral blood mononuclear cells in vitro. Chronobiol Int. 2005; 22(3):585-590.
220. van der Veen DR, Shao J, Xi Y, Li L, Duffield GE. Cardiac atrial circadian rhythms in PERIOD2::LUCIFERASE and per1:luc mice: amplitude and phase responses to glucocorticoid signaling and medium treatment. PLoS One. 2012;7(10):e47692.
221. Sandu C, Dumas M, Malan A, et al. Human skin keratinocytes, melanocytes, and fibroblasts contain distinct circadian clock machineries. Cell Mol Life Sci. 2012;69(19):3329-3339.
222. Chen H, Zhao L, Chu G, et al. FSH induces the development of circadian clockwork in rat granulosa cells via a gap junction protein Cx43-dependent pathway. Am J Physiol Endocrinol Metab. 2013;304(6):E566-E575.
223. James FO, Boivin DB, Charbonneau S, Bélanger V, Cermakian N. Expression of clock genes in human peripheral blood mononuclear cells throughout the sleep/wake and circadian cycles. Chronobiol Int. 2007;24(6):1009-1034.
224. Watanabe M, Hida A, Kitamura S, et al. Rhythmic expression of circadian clock genes in human leukocytes and beard hair follicle cells. Biochem Biophys Res Commun. 2012;425(4):902-907.
225. Charmandari E, Chrousos GP, Lambrou GI, et al. Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One. 2011; 6(9):e25612.
226. Fukuoka Y, Burioka N, Takata M, et al. Glucocorticoid administration increases hPer1 mRNA levels in human peripheral blood mononuclear cells in vitro or in vivo. J Biol Rhythms. 2005; 20(6):550-553.
227. Cuesta M, Cermakian N, Boivin DB. Glucocorticoids entrain molecular clock components in human peripheral cells. FASEB J. 2015;29(4):1360-1370.
228. Maronde E, Schilling AF, Seitz S, et al. The clock genes Period 2 and Cryptochrome 2 differentially balance bone formation. PLoS One. 2010;5(7):e11527.
229. Komoto S, Kondo H, Fukuta O, Togari A. Comparison of b-adrenergic and glucocorticoid signaling on clock gene and osteoblast-related gene expressions in human osteoblast. Chronobiol Int. 2012;29(1):66-74.
230. Fujihara Y, Kondo H, Noguchi T, Togari A. Glucocorticoids mediate circadian timing in peripheral osteoclasts resulting in the circadian expression rhythm of osteoclast-related genes. Bone. 2014;61:1-9.
231. Le Minh N, Damiola F, Tronche F, Schütz G, Schibler U. Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators.EMBOJ. 2001; 20(24):7128-7136.
232. Yang X, DownesM, Yu RT, et al.Nuclear receptor expression links the circadian clock to metabolism. Cell. 2006;126(4):801-810.
233. Rudic RD, McNamara P, Reilly D, et al. Bioinformatic analysis of circadian gene oscillation in mouse aorta. Circulation. 2005; 112(17):2716-2724.
234. Zvonic S, Ptitsyn AA, Kilroy G, et al. Circadian oscillation of gene expression in murine calvarial bone. J Bone Miner Res. 2007; 22(3):357-365.
235. Yang S, Wang K, Valladares O, Hannenhalli S, Bucan M. Genome-wide expression profiling and bioinformatics analysis of diurnally regulated genes in the mouse prefrontal cortex. Genome Biol. 2007;8(11):R247.
236. Nader N, Chrousos GP, Kino T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J. 2009;23(5): 1572-1583.
237. Lamia KA, Papp SJ, Yu RT, et al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature. 2011; 480(7378):552-556.
238. Goriki A, Hatanaka F, Myung J, et al. A novel protein, CHRONO, functions as a core component of the mammalian circadian clock. PLoS Biol. 2014;12(4):e1001839.
239. Han DH, Lee YJ, Kim K, Kim CJ, Cho S. Modulation of glucocorticoid receptor induction properties by core circadian clock proteins. Mol Cell Endocrinol. 2014;383(1-2):170-180.
240. Tomlinson JW, Walker EA, Bujalska IJ, et al. 11b-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 2004;25(5):831-866.
241. Graef V, Golf SW. Circadian rhythm of hepatic steroid metabolizing enzyme activities in the rat. J Steroid Biochem. 1979;11(3): 1299-1302.
242. Bureń J, Bergström SA, Loh E, Sö derström I, Olsson T, Mattsson C. Hippocampal 11b-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese Zucker rat. Endocrinology. 2007;148(6): 2716-2722.
243. Hernandez-Morante JJ, Gomez-Santos C, Milagro F, et al. Expression of cortisol metabolism-related genes shows circadian rhythmic patterns in human adipose tissue. Int J Obes (Lond). 2009;33(4):473-480.
244. Bisschop PH, Dekker MJ, Osterthun W, et al. Expression of 11b-hydroxysteroid dehydrogenase type 1 in the human hypothalamus. J Neuroendocrinol. 2013;25(5):425-432.
245. de Kloet ER. Functional profile of the binary brain corticosteroid receptor system: mediating, multitasking, coordinating, integrating. Eur J Pharmacol. 2013;719(1-3):53-62.
246. Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress. 2004;7(1):29-37.
247. Luger A, Deuster PA, Kyle SB, et al. Acute hypothalamicpituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med. 1987; 316(21):1309-1315.
248. Kudielka BM, Schommer NC, Hellhammer DH, Kirschbaum C. Acute HPA axis responses, heart rate, and mood changes to psychosocial stress (TSST) in humans at different times of day. Psychoneuroendocrinology. 2004;29(8):983-992.
249. Yehuda R, Seckl J. Minireview: stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis. Endocrinology. 2011;152(12):4496-4503.
250. Daskalakis NP, Claessens SE, Laboyrie JJ, et al. The newborn rat's stress system readily habituates to repeated and prolonged maternal separation, while continuing to respond to stressors in context dependent fashion. Horm Behav. 2011;60(2):165-176.
251. de Kloet ER, Karst H, Jöels M. Corticosteroid hormones in the central stress response: quick-and-slow. Front Neuroendocrinol. 2008;29(2):268-272.
252. Bose M, Oliván B, Laferrére B. Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. Curr Opin Endocrinol Diabetes Obes. 2009;16(5):340-346.
253. Haynes RC Jr. Studies of an vitro effect of glucocorticoids on gluconeogenesis. Endocrinology. 1962;71:399-406.
254. Malaisse WJ, Malaisse-Lagae F, McCraw EF, Wright PH. Insulin secretion in vitro by pancreatic tissue from normal, adrenalectomized, and cortisol-treated rats. Proc Soc Exp Biol Med. 1967; 124(3):924-928.
255. Solomon LM, Wentzel HE, Greenberg MS. Studies in the mechanism of steroid vasoconstriction. J Invest Dermatol. 1965; 44:129-131.
256. Campeau S, Liberzon I, Morilak D, Ressler K. Stress modulation of cognitive and affective processes. Stress. 2011;14(5): 503-519.
257. Meerlo P, van den Hoofdakker RH, Koolhaas JM, Daan S. Stressinduced changes in circadian rhythms of body temperature and activity in rats are not caused by pacemaker changes. J Biol Rhythms. 1997;12(1):80-92.
258. Yamamoto T, Nakahata Y, Tanaka M, et al. Acute physical stress elevates mouse period1 mRNA expression in mouse peripheral tissues via a glucocorticoid-responsive element. J Biol Chem. 2005;280(51):42036-42043.
259. Cheon S, ParkN, Cho S, KimK. Glucocorticoid-mediated Period2 induction delays the phase of circadian rhythm. Nucleic Acids Res. 2013;41(12):6161-6174.
260. Torra IP, Tsibulsky V, Delaunay F, et al. Circadian and glucocorticoid regulation of Rev-erba expression in liver. Endocrinology. 2000;141(10):3799-3806.
261. McEwen BS, Bowles NP, Gray JD, et al. Mechanisms of stress in the brain. Nat Neurosci. 2015;18(10):1353-1363.
262. Dallman MF. Stress-induced obesity and the emotional nervous system. Trends Endocrinol Metab. 2010;21(3):159-165.
263. Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E. Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation. 2015;22(1-2):6-19.
264. Hackett RA, Kivimäki M, Kumari M, Steptoe A. Diurnal cortisol patterns, future diabetes, and impaired glucose metabolism in the Whitehall II Cohort Study. J Clin Endocrinol Metab. 2016;101(2): 619-625.
265. Matthews K, Schwartz J, Cohen S, Seeman T. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med. 2006;68(5):657-661.
266. Sephton SE, Lush E, Dedert EA, et al. Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav Immun. 2013; 30(suppl):S163-S170.
267. Lupien SJ, de Leon M, de Santi S, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci. 1998;1(1):69-73.
268. McEwen BS, Stellar E. Stress and the individual.Mechanisms leading to disease. Arch Intern Med. 1993;153(18):2093-2101.
269. Scheen AJ, Buxton OM, Jison M, et al. Effects of exercise on neuroendocrine secretions and glucose regulation at different times of day. Am J Physiol. 1998;274(6 Pt 1): E1040-E1049.
270. Lecocq FR, Mebane D, Madison LL. The acute effect of hydrocortisone on hepatic glucose output and peripheral glucose utilization. J Clin Invest. 1964;43:237-246.
271. Askew EW, Huston RL, Plopper CG, Hecker AL. Adipose tissue cellularity and lipolysis. Response to exercise and cortisol treatment. J Clin Invest. 1975;56(3):521-529.
272. Challet E, le Maho Y, Robin JP, Malan A, Cherel Y. Involvement of corticosterone in the fasting-induced rise in protein utilization and locomotor activity. Pharmacol Biochem Behav. 1995;50(3): 405-412.
273. Pleasure DE, Walsh GO, Engel WK. Atrophy of skeletal muscle in patients with Cushing's syndrome. Arch Neurol. 1970;22(2): 118-125.
274. Hills OW, Power MH, Wilder RM. Diabetes mellitus and Cushing's syndrome: concentrations of lactate and pyruvate in blood after ingestion of glucose. Diabetes. 1952;1(5):351-357.
275. Hauner H, Entenmann G, Wabitsch M, et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest. 1989;84(5):1663-1670.
276. Hauner H, Schmid P, Pfeiffer EF. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab. 1987;64(4):832-835.
277. Nieuwenhuizen AG, Rutters F. The hypothalamic-pituitaryadrenal-axis in the regulation of energy balance. Physiol Behav. 2008;94(2):169-177.
278. Leliavski A, Dumbell R, Ott V, Oster H. Adrenal clocks and the role of adrenal hormones in the regulation of circadian physiology. J Biol Rhythms. 2015;30(1):20-34.
279. Plat L, Leproult R, L'Hermite-Baleriaux M, Fery F, Mockel J, Polonsky KS, Van Cauter E. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab. 1999;84(9): 3082-3092.
280. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188): 1435-1439.
281. Spiegel K, Leproult R, L'hermite-Balériaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab. 2004; 89(11):5762-5771.
282. Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. Circadian rhythms and cardiovascular health. Sleep Med Rev. 2012;16(2):151-166.
283. Shea SA, Hilton MF, Hu K, Scheer FA. Existence of an endogenous circadian blood pressure rhythm in humans that peaks in the evening. CircRes. 2011;108(8):980-984.
284. Ibanez B, Suarez-Barrientos A, Lopez-Romero P. Circadian variations of infarct size in STEM1. Circ Res. 2012;110(3):e22; author reply e23.
285. Scheer FA, Michelson AD, Frelinger AL 3rd, et al. The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS One. 2011;6(9):e24549.
286. Scheer FA, Shea SA. Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle. Blood. 2014;123(4):590-593.
287. Scheer FA, Hu K, Evoniuk H, et al. Impact of the human circadian system, exercise, and their interaction on cardiovascular function. Proc Natl Acad Sci USA. 2010;107(47):20541-20546.
288. Hu K, Scheer FA, Laker M, Smales C, Shea SA. Endogenous circadian rhythm in vasovagal response to head-up tilt. Circulation. 2011;123(9):961-970.
289. Kawachi I, Colditz GA, Stampfer MJ, et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation. 1995;92(11):3178-3182.
290. Eckle T, Hartmann K, Bonney S, et al. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med. 2012;18(5):774-782.
291. Baschant U, Lane NE, Tuckermann J. The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat Rev Rheumatol. 2012;8(11):645-655.
292. Palacios R, Sugawara I. Hydrocortisone abrogates proliferation of T cells in autologous mixed lymphocyte reaction by rendering the interleukin-2 Producer T cells unresponsive to interleukin-1 and unable to synthesize the T-cell growth factor. Scand J Immunol. 1982;15(1):25-31.
293. Snyder DS, Unanue ER. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol. 1982;129(5):1803-1805.
294. Fauci AS. Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin Exp Immunol. 1976;24(1):54-62.
295. Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol. 2010; 120(2-3):69-75.
296. Smolensky MH, Reinberg AE, Martin RJ, Haus E. Clinical chronobiology and chronotherapeutics with applications to asthma. Chronobiol Int. 1999;16(5):539-563.
297. Keller M, Mazuch J, Abraham U, et al. A circadian clock in macrophages controls inflammatory immune responses. Proc Natl Acad Sci USA. 2009;106(50):21407-21412.
298. Boivin DB, James FO, Wu A, Cho-Park PF, Xiong H, Sun ZS. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood. 2003;102(12):4143-4145.
299. Bollinger T, Leutz A, Leliavski A, et al. Circadian clocks in mouse and human CD41 T cells. PLoS One. 2011;6(12):e29801.
300. Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab. 2005;90(5):3106-3114.
301. Liston C, Cichon JM, Jeanneteau F, JiaZ, Chao MV, Gan WB. Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance. Nat Neurosci. 2013;16(6): 698-705.
302. De Kloet R, Wallach G, McEwen BS. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology. 1975;96(3):598-609.
303. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology. 1998;139(4):1789-1793.
304. Karssen AM, Meijer OC, Berry A, Sanjuan Piñol R, de Kloet ER. Low doses of dexamethasone can produce a hypocorticosteroid state in the brain. Endocrinology. 2005;146(12):5587-5595.
305. Rimmele U, Meier F, Lange T, Born J. Suppressing the morning rise in cortisol impairs free recall. Learn Mem. 2010;17(4):186-190.
306. Wilhelm I, Wagner U, Born J. Opposite effects of cortisol on consolidation of temporal sequence memory during waking and sleep. J Cogn Neurosci. 2011;23(12):3703-3712.
307. Groch S, Wilhelm I, Lange T, Born J. Differential contribution of mineralocorticoid and glucocorticoid receptors to memory formation during sleep. Psychoneuroendocrinology. 2013;38(12): 2962-2972.
308. Lightman SL, George CL. Steroid hormones in 2013: Glucocorticoids: timing, binding and environment. Nat Rev Endocrinol. 2014;10(2):71-72.
309. Hofman MA, Swaab DF. Living by the clock: the circadian pacemaker in older people. Ageing Res Rev. 2006;5(1):33-51.
310. Czeisler CA, Duffy JF, Shanahan TL, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999;284(5423):2177-2181.
311. Harper DG, Stopa EG, McKee AC, et al. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry. 2001;58(4):353-360.
312. Wu YH, Swaab DF. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med. 2007;8(6):623-636.
313. Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA. 2000;284(7):861-868.
314. Vgontzas AN, Zoumakis M, Bixler EO, et al. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab. 2003;88(5): 2087-2095.
315. Gardner MP, Lightman S, Sayer AA, et al. Dysregulation of the hypothalamic pituitary adrenal (HPA) axis and physical performance at older ages: an individual participant meta-analysis. Psychoneuroendocrinology. 2013;38(1):40-49.
316. Kumari M, Badrick E, Sacker A, Kirschbaum C, Marmot M, Chandola T. Identifying patterns in cortisol secretion in an older population. Findings from the Whitehall II study. Psychoneuroendocrinology. 2010;35(7):1091-1099.
317. Szosland D. Shift work and metabolic syndrome, diabetes mellitus and ischaemic heart disease. Int J Occup Med Environ Health. 2010;23(3):287-291.
318. Fritschi L, Glass DC, Heyworth JS, et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses. 2011; 77(3):430-436.
319. Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 2007; 47:593-628.
320. Bass J.Circadian topology ofmetabolism. Nature. 2012; 491(7424): 348-356.
321. Barclay JL, Husse J, Bode B, et al. Circadian desynchrony promotes metabolic disruption in a mouse model of shiftwork. PLoS One. 2012;7(5):e37150.
322. Husse J, Hintze SC, Eichele G, Lehnert H, Oster H. Circadian clock genes Per1 and Per2 regulate the response of metabolismassociated transcripts to sleep disruption. PLoS One. 2012;7(12): e52983.
323. Salgado-Delgado R, Angeles-Castellanos M, Buijs MR, Escobar C. Internal desynchronization in a model of nightwork by forced activity in rats. Neuroscience. 2008;154(3): 922-931.
324. Salgado-Delgado R, Nadia S, Angeles-Castellanos M, Buijs RM, Escobar C. In a rat model of night work, activity during the normal resting phase produces desynchrony in the hypothalamus. J Biol Rhythms. 2010;25(6):421-431.
325. Arendt J. Jet-lag and shift work: (2). Therapeutic use of melatonin. J R Soc Med. 1999;92(8):402-405.
326. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev. 2005;9(1):25-39.
327. Boivin DB, Boudreau P, Tremblay GM. Phototherapy and orangetinted goggles for night-shift adaptation of police officers on patrol. Chronobiol Int. 2012;29(5):629-640.
328. Boivin DB, Tremblay GM, James FO. Working on atypical schedules. Sleep Med. 2007;8(6):578-589.
329. Salgado-Delgado R, Angeles-Castellanos M, Saderi N, Buijs RM, Escobar C. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinology. 2010;151(3):1019-1029.
330. Herichova I. Changes of physiological functions induced by shift work. Endocr Regul. 2013;47(3):159-170.
331. Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20(10):865-870.
332. McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism. 2006;55(10 suppl 2):S20-S23.
333. Mongrain V, Hernandez SA, Pradervand S, et al. Separating the contribution of glucocorticoids and wakefulness to the molecular and electrophysiological correlates of sleep homeostasis. Sleep. 2010;33(9):1147-1157.
334. Vgontzas AN, Pejovic S, Zoumakis E, et al. Hypothalamicpituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab. 2007;92(11):4199-4207.
335. Kritikou I, BastaM, Vgontzas AN, et al. Sleep apnoea and the hypothalamic-pituitary-adrenal axis in men and women: effects of continuous positive airway pressure.EurRespir J. 2016;47(2):531-540.
336. Dadoun F, Darmon P, Achard V, et al. Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men. Am J Physiol Endocrinol Metab. 2007;293(2):E466-E474.
337. Tomfohr LM, Edwards KM, Dimsdale JE. Is obstructive sleep apnea associated with cortisol levels? A systematic review of the research evidence. Sleep Med Rev. 2012;16(3):243-249.
338. Terań-Pérez G, Arana-Lechuga Y, Esqueda-Leó n E, Santana-Miranda R, Rojas-Zamorano JA, Velazquez Moctezuma J. Steroid hormones and sleep regulation. Mini Rev Med Chem. 2012; 12(11):1040-1048.
339. Balbo M, Leproult R, Van Cauter E. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int J Endocrinol. 2010;2010:759234.
340. Kumari M, Chandola T, Brunner E, Kivimaki M. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab. 2010;95(9):4415-4423.
341. Hackett RA, Steptoe A, Kumari M. Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J Clin Endocrinol Metab. 2014;99(12):4625-4631.
342. Papaioannou I, Twigg GL, Kemp M, et al. Melatonin concentration as a marker of the circadian phase in patients with obstructive sleep apnoea. Sleep Med. 2012;13(2):167-171.
343. Bierwolf C, Kern W, Mö lle M, Born J, Fehm HL. Rhythms of pituitary-adrenal activity during sleep in patients with Cushing's disease. Exp Clin Endocrinol Diabetes. 2000;108(7):470-479.
344. Fehm HL, Benkowitsch R, Kern W, Fehm-Wolfsdorf G, Pauschinger P, Born J. Influences of corticosteroids, dexamethasone and hydrocortisone on sleep in humans. Neuropsychobiology. 1986;16(4):198-204.
345. Born J, Zwick A, Roth G, Fehm-Wolfsdorf G, Fehm HL. Differential effects of hydrocortisone, fluocortolone, and aldosterone on nocturnal sleep in humans. Acta Endocrinol (Copenh). 1987; 116(1):129-137.
346. Vgontzas AN, Zoumakis M, Papanicolaou DA, et al. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism. 2002;51(7):887-892.
347. Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol. 2011;8(1):22-32.
348. Crofford LJ, Young EA, Engleberg NC, et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun. 2004;18(4):314-325.
349. Klerman EB, Goldenberg DL, Brown EN, Maliszewski AM, Adler GK. Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab. 2001;86(3):1034-1039.
350. Prague JK, May S, Whitelaw BC. Cushing's syndrome. BMJ. 2013;346:f945.
351. Feelders RA, Hofland LJ. Medical treatment of Cushing's disease. J Clin Endocrinol Metab. 2013;98(2):425-438.
352. Van Cauter E, Refetoff S. Evidence for two subtypes of Cushing's disease based on the analysis of episodic cortisol secretion.NEngl J Med. 1985;312(21):1343-1349.
353. van Aken MO, Pereira AM, van Thiel SW, et al. Irregular and frequent cortisol secretory episodes with preserved diurnal rhythmicity in primary adrenal Cushing's syndrome. J Clin Endocrinol Metab. 2005;90(3):1570-1577.
354. Terzolo M, Piovesan A, A, et al. Circadian profile of serum melatonin in patients with Cushing's syndrome or acromegaly. J Endocrinol Invest. 1995;18(1):17-24.
355. Kö bberling J, zur Mühlen A von. The circadian rhythm of free cortisol determined by urine sampling at two-hour intervals in normal subjects and in patients with severe obesity or Cushing's syndrome. J Clin Endocrinol Metab. 1974;38(2):313-319.
356. Iwami T, Nakamura T, Niwamae N, Yamagishi T, Utsugi T, Nagai R. Pre-clinical Cushing's syndrome with body weight loss and normal circadian rhythm of blood pressure. Intern Med. 1998;37(6):528-533.
357. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540.
358. Sundaram NK, Carluccio A, Geer EB. Characterization of persistent and recurrent Cushing's disease. Pituitary. 2014;17(4): 381-391.
359. Nieman LK, Chanco Turner ML. Addison's disease. Clin Dermatol. 2006;24(4):276-280.
360. Cugini P, Letizia C, Cerci S, et al. A chronobiological approach to circulating levels of renin, angiotensin-converting enzyme, aldosterone, ACTH, and cortisol in Addison's disease. Chronobiol Int. 1993;10(2):119-122.
361. Giebels V, Repping-Wuts H, Bleijenberg G, Kroese JM, Stikkelbroeck N, Hermus A. Severe fatigue in patients with adrenal insufficiency: physical, psychosocial and endocrine determinants. J Endocrinol Invest. 2014;37(3):293-301.
362. Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361(9372): 1881-1893.
363. Arlt W, Rosenthal C, Hahner S, Allolio B. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf). 2006; 64(4):384-389.
364. Grossman A, Johannsson G, Quinkler M, Zelissen P. Therapy of endocrine disease: perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol. 2013;169(6):R165-R175.
365. Barthel A, Willenberg HS, Gruber M, Bornstein SR. Adrenal insufficiency. In: Jameson JL, De Groot LJ, eds. Endocrinology: Adult and Pediatric. 7th ed. Philadelphia, PA: Saunders; 2015: 1763-1774.
366. Johannsson G, Falorni A, Skrtic S, et al. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 2015;82(1):2-11.
367. Chan S, Debono M. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy. Ther Adv Endocrinol Metab. 2010;1(3):129-138.
368. Løv as K, Husebye ES. Replacement therapy for Addison's disease: recent developments. Expert Opin Investig Drugs. 2008;17(4): 497-509.
369. Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012;169(5):491-497.
370. Judd LL, Schettler PJ, Brown ES, et al. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry. 2014;171(10):1045-1051.
371. KarssenAM, MeijerOC, van der Sandt IC, De BoerAG, De Lange EC, De Kloet ER. The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone. J Endocrinol. 2002;175(1):251-260.
372. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002;7(3):254-275.
373. Linkowski P, Mendlewicz J, Kerkhofs M, et al. 24-hour profiles of adrenocorticotropin, cortisol and growth hormone in major depressive illness: Effect of anti-depressant treatment. J Clin Endocrinol Metab. 1987;65(1):141-152.
374. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry. 1987;44(4):328-336.
375. Antonijevic I. HPA axis and sleep: identifying subtypes of major depression. Stress. 2008;11(1):15-27.
376. Linkowski P, Mendlewicz J, Kerkhofs M, et al. 24-Hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab. 1987;65(1):141-152.
377. Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010;11(8):589-599.
378. Coogan AN, Thome J. Chronotherapeutics and psychiatry: setting the clock to relieve the symptoms. World J Biol Psychiatry. 2011; 12(suppl 1):40-43.
379. Benedetti F, Barbini B, Colombo C, Smeraldi E. Chronotherapeutics in a psychiatric ward. Sleep Med Rev. 2007;11(6): 509-522.
380. Dallman MF, Akana SF, Bhatnagar S, Bell ME, Strack AM. Bottomed out: metabolic significance of the circadian trough in glucocorticoid concentrations. Int J Obes Relat Metab Disord. 2000;24(suppl 2):S40-S46.
381. Morris MC, Compas BE, Garber J. Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin Psychol Rev. 2012;32(4):301-315.
382. Meewisse ML, Reitsma JB, de Vries GJ, Gersons BP, Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br J Psychiatry. 2007;191:387-392.
383. van Liempt S, Arends J, Cluitmans PJ, Westenberg HG, Kahn RS, Vermetten E. Sympathetic activity and hypo-thalamopituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology. 2013; 38(1):155-165.
384. Herpertz S, Albers N, Wagner R, et al. Longitudinal changes of circadian leptin, insulin and cortisol plasma levels and their correlation during refeeding in patients with anorexia nervosa. Eur J Endocrinol. 2000;142(4):373-379.
385. Putignano P, Dubini A, TojaP, et al. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur J Endocrinol. 2001;145(2):165-171.
386. Monteleone P, Di Lieto A, Tortorella A, Longobardi N, Maj M. Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatry Res. 2000;94(2):121-129.
387. Ferrari E, Fraschini F, Brambilla F. Hormonal circadian rhythms in eating disorders. Biol Psychiatry. 1990;27(9):1007-1020.
388. Goel N, Stunkard AJ, Rogers NL, et al. Circadian rhythm profiles in women with night eating syndrome. J Biol Rhythms. 2009; 24(1):85-94.
389. Allison KC, Ahima RS, O'Reardon JP, et al. Neuroendocrine profiles associated with energy intake, sleep, and stress in the night eating syndrome. J Clin Endocrinol Metab. 2005;90(11): 6214-6217.
390. Birketvedt GS, Florholmen J, Sundsfjord J, et al. Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA. 1999;282(7):657-663.
391. Rimmele U, Besedovsky L, Lange T, Born J. Emotional memory can be persistently weakened by suppressing cortisol during retrieval. Neurobiol Learn Mem. 2015;119:102-107.
392. Guelho D, Grossman AB. Emerging drugs for Cushing's disease. Expert Opin Emerg Drugs. 2015;20(3):463-478.
393. Bertagna X, Guignat L. Approach to the Cushing's disease patient with persistent/recurrent hypercortisolism after pituitary surgery. J Clin Endocrinol Metab. 2013;98(4):1307-1318.
394. Ferrier IN, Anderson IM, Barnes J, et al. Randomised controlled trial of Antiglucocorticoid augmentation (metyrap-one) of anti-Depressants in Depression (ADD Study). Efficacy Mech Eval. 2015;2(4):1-126.
395. Macfarlane DP, Raubenheimer PJ, Preston T, et al. Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with type 2 diabetes with and without fatty liver. Am J Physiol Gastrointest Liver Physiol. 2014;307(7):G760-G768.
396. Daniel E, Aylwin S, Mustafa O, et al. Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients. JClin Endocrinol Metab. 2015;100(11):4146-4154.
397. Dunlop D. Eighty-six cases of Addison's disease. Br Med J. 1963; 2(5362):887-891.
398. Rosén T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336(8710): 285-288.
399. Ross IL, Bergthorsdottir R, Levitt NS, SchatzDA, Johannsson G, Marais AD. Increased cardiovascular risk in South African patients with Addison's disease. Horm Metab Res. 2013;45(12): 905-910.
400. Tiemensma J, Andela CD, Kaptein AA, et al. Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature. Eur J Endocrinol. 2014;171(2): 171-182.
401. Hahner S, Loeffler M, Fassnacht M, et al. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab. 2007;92(10):3912-3922.
402. Løv as K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf). 2002;56(5):581-588.
403. Husebye ES, Allolio B, Arlt W, et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med. 2014;275(2):104-115.
404. Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009; 68(7):1119-1124.
405. Kwon S, Hermayer KL. Glucocorticoid-induced hyperglycemia. Am J Med Sci. 2013;345(4):274-277.
406. Løv as K, Gjesdal CG, Christensen M, et al. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol. 2009;160(6):993-1002.
407. Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf). 1997;46(3):263-268.
408. Ceccato F, Albiger N, Reimondo G, et al. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. Eur J Endocrinol. 2012;167(6):769-776.
409. Thomson AH, Devers MC, Wallace AM, et al. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency. Clin Endocrinol (Oxf). 2007;66(6):789-796.
410. Crown A, Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf). 2005;63(5):483-492.
411. Debono M, Ross RJ, Newell-Price J. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol. 2009;160(5):719-729.
412. Hahner S, AllolioB.Therapeuticmanagement of adrenal insufficiency. Best Pract Res Clin Endocrinol Metab. 2009;23(2):167-179.
413. Forss M, Batcheller G, Skrtic S, Johannsson G. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency-a worldwide patient survey. BMC Endocr Disord. 2012;12:8.
414. Løv as K, Husebye ES, Holsten F, Bjorvatn B. Sleep disturbances in patients with Addison's disease. Eur J Endocrinol. 2003;148(4): 449-456.
415. Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol. 2009;161(1):119-130.
416. Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012;97(2):473-481.
417. Nilsson AG, Marelli C, Fitts D, et al. Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency. Eur J Endocrinol. 2014;171(3):369-377.
418. Bjö rnsdottir S, Øksnes M, Isaksson M, et al. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 2015;83(1):28-35.
419. Gagliardi L, Nenke MA, Thynne TR, et al. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2014;99(11):4149-4157.
420. Løv °as K, Husebye ES. Continuous subcutaneous hydrocortisone infusion in Addison's disease. Eur J Endocrinol. 2007; 157(1):109-112.
421. Oksnes M, Bjö rnsdottir S, Isaksson M, et al. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: a randomized clinical trial. J Clin Endocrinol Metab. 2014;99(5):1665-1674.
422. Russell GM, Durant C, Ataya A, et al. Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 2014; 81(2):289-293.
423. Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol. 2009;72(1):67-73.
424. Debono M, Ross RJ. Optimal glucocorticoid therapy. Endocr Dev. 2011;20:173-180.
425. Newell-Price J, Whiteman M, Rostami-Hodjegan A, et al. Modified-release hydrocortisone for circadian therapy: a proofof-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf). 2008;68(1):130-135.
426. Debono M, Ghobadi C, Rostami-Hodjegan A, et al. Modifiedrelease hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94(5):1548-1554.
427. Mallappa A, Sinaii N, Kumar P, et al. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2015;100(3):1137-1145.
428. Arendt J. Melatonin: characteristics, concerns, and prospects. J Biol Rhythms. 2005;20(4):291-303.
429. Molina TA, Burgess HJ. Calculating the dim light melatonin onset: the impact of threshold and sampling rate. Chronobiol Int. 2011;28(8):714-718.
430. Burgess HJ, Wyatt JK, Park M, Fogg LF. Home circadian phase assessments with measures of compliance yield accurate dim light melatonin onsets. Sleep. 2015;38(6):889-897.
431. Pagani L, Semenova EA, Moriggi E, et al. The physiological period length of the human circadian clock in vivo is directly proportional to period in human fibroblasts. PLoS One. 2010;5(10):e13376.
432. Hasan S, Santhi N, Lazar AS, et al. Assessment of circadian rhythms in humans: comparison of real-time fibroblast reporter imaging with plasma melatonin. FASEB J. 2012;26(6): 2414-2423.
433. Akashi M, Soma H, Yamamoto T, et al. Noninvasive method for assessing the human circadian clock using hair follicle cells. Proc Natl Acad Sci USA. 2010;107(35):15643-15648.
434. Archer SN, Oster H. How sleep and wakefulness influence circadian rhythmicity: effects of insufficient and mistimed sleep on the animal and human transcriptome. J Sleep Res. 2015;24(5): 476-493.
435. Van Cauter E. Physiology and pathology of circadian rhythms. In: Edwards CW, Lincoln DW, eds. Recent Advances in Endocrinology and Metabolism. Vol. 3. Edinburgh, UK: Churchill Livingstone; 1989:109-134.